PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34579738-0	2021	Correction to: YM155 decreases radiation-induced invasion and reverses epithelial-mesenchymal transition by targeting STAT3 in glioblastoma.	YM 155	15-20	signal transducer and activator of transcription 3	Homo sapiens	118-123	
26547260-10	2015	Treatment with YM155 combined with the STAT3 inhibitor S3I-201 significantly suppressed cell proliferation compared to that with either YM155 or S3I-201 in MT-2 cells, indicating that STAT3 may play a role in tolerance of MT-2 cells to YM155 and that STAT3 may therefore be a therapeutic target for YM155-resistant ATL cells.	YM 155	15-20	signal transducer and activator of transcription 3	Homo sapiens	39-44	
33658937-10	2020	Following that, we explored what elements are involved in the anti-apoptotic mechanism of activated STAT3 by using survivin inhibitor YM155.	YM 155	134-139	signal transducer and activator of transcription 3	Homo sapiens	100-105	
29571296-0	2018	YM155 decreases radiation-induced invasion and reverses epithelial-mesenchymal transition by targeting STAT3 in glioblastoma.	YM 155	0-5	signal transducer and activator of transcription 3	Homo sapiens	103-108	
29571296-11	2018	STAT3 was one of 10 molecules identified on a phosphokinase array exhibiting significant change in phosphorylation under YM155 treatment.	YM 155	121-126	signal transducer and activator of transcription 3	Homo sapiens	0-5	
29340073-6	2017	YM155 abrogated the interleukin-6-induced STAT3 phosphorylation, subsequently blocked Mcl-1 expression and induced apoptosis in MM cells.	YM 155	0-5	signal transducer and activator of transcription 3	Homo sapiens	42-47	
26547260-10	2015	Treatment with YM155 combined with the STAT3 inhibitor S3I-201 significantly suppressed cell proliferation compared to that with either YM155 or S3I-201 in MT-2 cells, indicating that STAT3 may play a role in tolerance of MT-2 cells to YM155 and that STAT3 may therefore be a therapeutic target for YM155-resistant ATL cells.	YM 155	15-20	signal transducer and activator of transcription 3	Homo sapiens	184-189	
26547260-10	2015	Treatment with YM155 combined with the STAT3 inhibitor S3I-201 significantly suppressed cell proliferation compared to that with either YM155 or S3I-201 in MT-2 cells, indicating that STAT3 may play a role in tolerance of MT-2 cells to YM155 and that STAT3 may therefore be a therapeutic target for YM155-resistant ATL cells.	YM 155	15-20	signal transducer and activator of transcription 3	Homo sapiens	184-189	
23746965-3	2013	YM155 synergistically enhanced STAT3 inhibitors (AG490 and STA-21)-induced apoptosis in DLBCL cell lines.	YM 155	0-5	signal transducer and activator of transcription 3	Homo sapiens	31-36	
25296978-7	2014	Gene expression and protein profiling revealed the critical roles of IL6/STAT3-signaling and the unfolded protein response in the efficacy of YM155.	YM 155	142-147	signal transducer and activator of transcription 3	Homo sapiens	73-78